The complete solution brief for life sciences software

Bonterra needed a sales-enablement asset to position CyberGrants for a highly technical, high-stakes buyer: medical affairs teams at life sciences companies still managing grantmaking programs on spreadsheets and disconnected systems. The brief was designed to move a skeptical enterprise reader from problem to proof—opening with the operational and compliance risks of fragmented workflows, then breaking down platform capabilities across expanded access, medical education, and investigator-sponsored research. To make the argument as credible as possible for a risk-averse audience, we anchored the narrative in outcome-backed case studies from Sanofi and Novartis, including approval times reduced from 5 days to less than 5 hours. The result demonstrates B2B enterprise content that balances regulatory precision with a commercial case for change.